Sensei biotherapeutics inc.

Major-Pharmaceuticals

SNSE


Executive/
Director

Price

  • Last Close
  • $ 0.46
    $ -0.11 -19.12 %
    Dec 9, 2024
  • 52-Week High/Low
  • $1.17 - $0.53
  • YTD
  • -33.4%

  • Trading Volume
  • 611
  • Market Cap Full
  • $ 11.5M
  • Shares Outstanding
  • 25M
    Nov 2, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -60.2% 0.7% 51.7%
Q2 - - - - - - -32.8% -1.7% -24% -7.1%
Q3 - - - - - - 7.8% -31.7% -34.2% -
Q4 - - - - - - -44.9% -3.9% -7.7% -
J F M A M J J A S O N D
2024 18.5% 3.7% 23.5% -7.1% - - - - - - - -
2023 -6% 12.1% -4.5% -2.7% - -21.9% 10.5% -20.6% -25% -5.2% 1.3% -3.9%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-74%-54%-33%

Earnings

2021 2022 2023
Q1 -0.42 -0.4 -0.33
Q2 -0.32 -0.34 -0.31
Q3 -0.32 -0.44 -0.28
Q4 -0.27 -0.40 -
A -1.3 -1.6 -0.92

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 30.7 31
Jun 30.6 30.6 31
Sep 30.6 30.7 26.6
Dec 30.6 30.7 25

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - 0.1 - -
Debt – Equity Ratio - - - - -
Interest Coverage 50 - -19 -2.4 -
Equity multiplier - - - - -